Targeting the B Cell Response to Treat Antibody-Mediated Rejection — Stuart Johnston Knechtle (DUKE UNIVERSITY)
ABSTRACT Antibody-mediated rejection (AMR) of solid organ transplants is the leading cause of immunologic graft injury, shortening the half-life of transplants and consequently of transplant recipient
| Project title | Targeting the B Cell Response to Treat Antibody-Mediated Rejection |
|---|---|
| Project number | 5U01AI163065-04 |
| PI name | Stuart Johnston Knechtle |
| Institution | DUKE UNIVERSITY |
| Funding mechanism | U01 |
| Agency | NIAID |
| Award amount | $2.57M |
| Fiscal year | 2024 |
| Project start | 2021-08-20T00:00:00 |
| Project end | 2028-05-31T00:00:00 |
| Abstract | ABSTRACT Antibody-mediated rejection (AMR) of solid organ transplants is the leading cause of immunologic graft injury, shortening the half-life of transplants and consequently of transplant recipient |
| Key terms | <Affect><Alloantibodies><Allogenic><Allografting><American><Antibodies><Antibody Therapy><Antibody-P |
$799/mo
Try GrantRadar →